Post-IPO Equity - Wave Life Sciences
Investment Firm
Overview
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Announced Date
Dec 13, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Wave Life Sciences raised $50000000 on 2022-12-13 in Post-IPO Equity
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 01, 2017 |  Post-IPO Equity - Wave Life Sciences | - | 100.0M | |
| Dec 14, 2015 | Post-IPO Equity - Wave Life Sciences | 1 | - | 30.0M |
| Aug 18, 2015 | Series B - Wave Life Sciences | 7 | - | 66.0M |
| Feb 02, 2015 | Series A - Wave Life Sciences | 2 | - | 18.0M |
Recent Activity
There is no recent news or activity for this profile.